Emergence of Lamivudine-Resistant HBV during Antiretroviral Therapy Including Lamivudine for Patients Coinfected with HIV and HBV in China

In China, HIV-1-infected patients typically receive antiretroviral therapy (ART) that includes lamivudine (3TC) as a reverse-transcriptase inhibitor (RTI) (ART-3TC). Previous studies from certain developed countries have shown that, in ART-3TC, 3TC-resistant HBV progressively emerges at an annual ra...

詳細記述

保存先:
書誌詳細
出版年:PLoS One
主要な著者: Gu, Lijun, Han, Yang, Li, Yijia, Zhu, Ting, Song, Xiaojing, Huang, Ying, Yang, Feifei, Guan, Shuo, Xie, Jing, Gohda, Jin, Hosoya, Noriaki, Kawana-Tachikawa, Ai, Liu, Wenjun, Gao, George Fu, Iwamoto, Aikichi, Li, Taisheng, Ishida, Takaomi
フォーマット: Artigo
言語:Inglês
出版事項: Public Library of Science 2015
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4543549/
https://ncbi.nlm.nih.gov/pubmed/26288093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0134539
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料